VIETNAM PHARMACEUTICAL CORPORATION
ActiveVIETNAM PHARMACEUTICAL CORPORATION
ActiveVIETNAM PHARMACEUTICAL CORPORATION
ActiveSummary
A review of the company report, ownership structure, certificate of incorporation, and financial statement indicates that VIETNAM PHARMACEUTICAL CORPORATION, registered under Business ID (TIN) 0100109385, is headquartered at No. 12, Ngo Tat To Street, Van Mieu Ward, Dong Da District, Ha Noi City, Vietnam.
Founded on 27 Jan 2011, it specializes in the manufacture of pharmaceuticals, medicinal chemical and botanical products sector, offering a comprehensive range of products and services. The company's sales are on an uptrend. With a charter capital of VND 2,370,000,000,000, VIETNAM PHARMACEUTICAL CORPORATION is financially well-positioned to support its operations. DINH X.H. and HAN T.K.V. lead strategic decisions, ensuring effective leadership and business direction.
National Phytopharma is Vietnam's largest pharmaceutical enterprise by revenue, reporting USD 1.44 billion in 2023. It plays a critical role in the national supply chain, particularly in trading and distributing essential drugs and medical products. Its headquarters and operational base are aligned with public sector procurement programs.
Despite this scale, the company reported modest profits of USD 4.49 million in 2023, with low profit margins highlighting the challenges of operating in a price-sensitive market. Total assets reached USD 570.46 million, while owner's equity stood at USD 22.42 million, reflecting its heavy reliance on working capital and infrastructure.
While National Phytopharma lacks the profit intensity of its peers, VBI ranks it highly for its vast scale, state-linked distribution capacity, and foundational role in national medicine logistics. Profitability improvements remain a key opportunity area.
Legal Profile
Contacts
+ DINH X.H
+ HAN T.K.V
Business Sector
Key business lines:
Industry Sales Growth
-2.80%
-5.39%
Companies by industry
1,859
0.0639%
Key Industry Players
Payment History
Financial Performance
| Assets | 89.29% |
| Owner’s Equity | 42.15% |
| Working Capital | -83.37% |
| Net Worth | -60.92% |
| Sales | -1.84% |
| Operating income | -40.28% |
| EBIT | -73.37% |
| Gross Profit Margin | -8.75% |
| Debt to EBITDA | -17.71% |